Summary: Researchers report the first direct experimental evidence showing how the severity of genetic mutations changes sex-specific vulnerability to autism spectrum disorder (ASD). Autism is diagnosed about four times more often in males than in females, which has led scientists to propose that females possess biological protective mechanisms. This study establishes that while mild CHD8 mutations tend to spare females, severe CHD8 disruption can overwhelm female protection and produce robust ASD-like features in both sexes.
A collaborative team from KAIST, Yonsei University, and the Institute for Basic Science engineered the world’s first viable homozygous CHD8-mutant mouse model — a model that reveals how mutation strength affects sex differences in autism-related brain development and behavior. By comparing mice with one mutated CHD8 copy (heterozygous) to mice with two mutated copies (homozygous) on a hybrid genetic background, the researchers mapped how increasing mutation severity broadens vulnerability across sexes and amplifies neural dysfunction.
Key Facts
- Autism sex gap: Clinically, ASD is diagnosed roughly four times more frequently in boys than girls, suggesting intrinsic female resilience in many cases.
- CHD8 role: CHD8 is a major chromatin remodeler and high-ranking genetic risk factor for ASD. It regulates networks of genes essential for early brain development by shaping chromatin structure and gene expression.
- Overcoming embryonic lethality: Prior attempts to create animals with mutations in both CHD8 copies failed because those embryos did not survive. Introducing the mutation into a hybrid (C57BL6/J × 129/Sv) genetic background produced viable homozygous mutants for the first time.
- Severity-dependent sex effects: Heterozygous CHD8 mutants displayed male-biased behavioral abnormalities, aligning with human sex prevalence. By contrast, homozygous CHD8 mutants exhibited pronounced ASD-like features in both males and females.
- Wide-ranging neural disruption: Severe CHD8 mutation caused increased brain volume, reduced cerebral blood flow, altered brain rhythms, impaired synaptic transmission and extensive changes in gene expression affecting synaptic signaling, RNA splicing, and mitochondrial function.
- Dynamic sex differences: The study demonstrates that female protection against ASD is not absolute. As CHD8 disruption intensifies, sex differences attenuate — female resilience progressively breaks down as mutation strength rises.
Source: Institute for Basic Science
Autism spectrum disorder affects males more often than females, with diagnoses occurring roughly four times more frequently in boys. This long-standing observation suggested that females possess biological mechanisms that reduce ASD vulnerability, but direct experimental confirmation of how these protections operate has been limited until now.
The research team produced viable homozygous CHD8-mutant mice carrying a clinically relevant human mutation (CHD8-Asn2373LysfsX2) on a hybrid genetic background, enabling direct comparisons between mild and severe gene disruption. This approach allowed analysis across developmental stages of brain structure, neural activity, behavior, and gene expression.
Heterozygous mice (one mutated CHD8 copy) reproduced the expected male-predominant behavioral deficits observed in many prior models and in human epidemiology. In striking contrast, homozygous CHD8 mutants (both copies mutated) displayed strong ASD-related phenotypes in both sexes, erasing much of the typical male–female difference. These homozygous animals also showed enlarged brain volume, altered cerebral blood flow, disrupted brain oscillations, reduced synaptic transmission and broad transcriptomic alterations tied to synaptic function, RNA splicing and mitochondrial biology.
Lead investigators emphasize that these results reveal a gene dosage effect: as CHD8 disruption increases, sex-specific protection diminishes. This provides a mechanistic explanation for why some severe neurodevelopmental presentations affect males and females more equally and suggests that sex differences in ASD are context-dependent, shaped by mutation strength and genetic background.
Beyond autism, CHD8 is implicated in several neurodevelopmental disorders including ADHD, intellectual disability and schizophrenia. The finding that mutation severity modulates sex-specific vulnerability has implications for understanding and treating a range of brain disorders linked to chromatin regulation.
Professor Eunee Lee (Yonsei University) noted that female biological mechanisms can protect against CHD8-related dysfunction at lower mutation loads but are vulnerable to severe disruptions. Director Eunjoon Kim (IBS Center for Synaptic Brain Dysfunctions) added that these results establish a foundation for precision therapeutics that account for both biological sex and mutation severity when designing interventions.
Key Questions Answered
A: The higher male diagnosis rate has suggested that females possess intrinsic protective biology that reduces ASD susceptibility. This study shows those protections are effective against mild genetic disruptions but can be overcome by stronger, homozygous mutations in key risk genes like CHD8.
A: The team introduced the human CHD8 mutation into a hybrid genetic background (C57BL6/J × 129/Sv). This genetic context allowed embryos with two mutated CHD8 copies to survive, enabling the first direct study of severe CHD8 dysfunction across development.
A: No. Biological sex remains important, but its influence depends on mutation severity. The study shows sex differences can diminish as mutation strength increases, highlighting the need for precision medicine approaches that consider both sex and specific genetic burden.
Editorial Notes
- This article was edited by a Neuroscience News editor.
- The full journal article was reviewed in detail.
- Additional context and explanation were provided by editorial staff.
About this research and reporting
Author: William Suh
Source: Institute for Basic Science
Contact: William Suh – Institute for Basic Science
Image credit: Neuroscience News
Original Research: Open access. Article titled “Homozygous CHD8 mutation intensifies ASD phenotypes and attenuates sex differences” published in Molecular Psychiatry. Authors include Jinkyeong Kim and colleagues. DOI: 10.1038/s41380-026-03646-9.
Abstract (summary)
CHD8, a chromatin remodeler linked to autism and other neurodevelopmental disorders, has unclear in vivo effects because heterozygous mouse lines often show only mild phenotypes and homozygous knockout typically causes embryonic lethality. By creating viable homozygous CHD8 mutant mice carrying a human frameshift mutation on a hybrid genetic background, researchers observed stronger ASD-related traits, including increased behavioral deficits, larger brain volume, reduced cerebral blood volume/flow, disrupted neuronal firing and synaptic transmission, and broad transcriptomic changes. Importantly, whereas heterozygous mutants primarily showed male-specific behavioral deficits, homozygous mutants exhibited pronounced phenotypes in females as well, indicating that mutation strength and genetic background jointly determine sex-specific vulnerability. Transcriptomic data implicate synaptic, RNA splicing and mitochondrial pathways in mediating these effects, linking gene dosage to the attenuation of sexual dimorphism in ASD.